At the time of writing, FibroBiologics Inc [FBLG] stock is trading at $0.26, down -5.40%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The FBLG shares have lost -24.96% over the last week, with a monthly amount drifted -21.01%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
FibroBiologics Inc [NASDAQ: FBLG] stock has seen the most recent analyst activity on December 12, 2024, when Rodman & Renshaw initiated its Buy rating and assigned the stock a price target of $12. Previously, H.C. Wainwright started tracking the stock with Buy rating on October 30, 2024, and set its price target to $12. On September 24, 2024, Maxim Group initiated with a Buy rating and assigned a price target of $12 on the stock.
For the past year, the stock price of FibroBiologics Inc fluctuated between $0.24 and $2.51. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. FibroBiologics Inc [NASDAQ: FBLG] shares were valued at $0.26 at the most recent close of the market. An investor can expect a potential return of 3361.54% based on the average FBLG price forecast.
Analyzing the FBLG fundamentals
Gross Profit Margin for this corporation currently stands at 0.13% with Operating Profit Margin at -29.03%, Pretax Profit Margin comes in at -23.87%, and Net Profit Margin reading is -23.87%. To continue investigating profitability, this company’s Return on Assets is posted at -0.95, Equity is -6.09 and Total Capital is -5.47. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 12.53.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.2483 points at the first support level, and at 0.2356 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.2768, and for the 2nd resistance point, it is at 0.2926.
Ratios To Look Out For
It is important to note that FibroBiologics Inc [NASDAQ:FBLG] has a current ratio of 0.78. Also, the Quick Ratio is 0.78, while the Cash Ratio stands at 0.81.
Transactions by insiders
Recent insider trading involved GARCIA RUBEN A, General Counsel, that happened on Dec 11 ’25 when 0.14 million shares were purchased. Chief Scientific Officer, Khoja Hamid completed a deal on May 27 ’25 to buy 20000.0 shares.
